IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Triantafyllia R. KarakousiiD, Vanessa CristaldiiD, Maria Luiza Lopes de OliveiraiD, Ines DelclauxiD, Naomi R. BessoniD, Luiz Henrique GeraldoiD, Tania J González-RoblesiD, Devyon R. McDonnough, Daniel Martinez-KramsiD, Gabrielle SilvaiD, Alec P. BreazealeiD, Joel Encarnación-RosadoiD, Joanna PoźniakiD, Shi QiuiD, Irineu Illa Bochaca, Medard ErnestiD, Hye Mi KimiD, Tullia Carmela BrunoiD, Boris ReizisiD, Ata S. MoshiriiD, Alec C. KimmelmaniD, Kelly V. RugglesiD, Iman OsmaniD, Jean‐Christophe MarineiD, Navdeep S. ChandeliD, Amanda W. LundiD
Abstract
Lymphatic vessels play a crucial role in activating anti-tumor immune surveillance but also contribute to metastasis and systemic tumor progression. Whether distinct lymphatic phenotypes exist that govern the switch between immunity and metastasis remains unclear. Here we reveal that cytotoxic immunity normalizes lymphatic function and uncouples immune and metastatic potential. We find that in mice and humans, intratumoral lymphatic vessel density negatively correlates with productive cytotoxic immune responses and identify IFN{gamma} as an intrinsic inhibitor of lymphangiogenesis. Specific deletion of the Ifngr1 in lymphatic endothelial cells (LECs) greatly expanded the intratumoral lymphatic network and drove the emergence of a tip-like endothelial state, promoting lymph node metastasis but not dendritic cell migration. IFN{gamma} inhibits oxidative phosphorylation, which is required for proliferation and acquisition of the pathologic transcriptional state. Our data indicate that IFN{gamma} induces a phenotypic switch in tumor-associated lymphatic vessels to reinforce canonical immune surveillance and block metastasis.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 11
- FWCI
- 28.53
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Melanoma evolution in the lymph node shapes systemic outcomes
Katherine S. Ventre, Tara Muijlwijk, … Amanda W. Lund·bioRxiv·Sep 17, 2026
- Interferon-Gamma Signaling Promotes Melanoma Progression and Metastasis
B. Zhou, J. Basu, … M. R. Zaidi·bioRxiv·Oct 14, 2021
- A critical role of VEGFR2 in lymphatic tumor metastasis
- Invadopodia-Mediated Remodeling of the Lymphatic Endothelium Drives Cancer Cell Lymphatic Dissemination and is Regulated by a CCR7-Vav2-Rac3 Signaling axis.
Sumreen Javed, Merlyn Emmanuel, … Karla C. Williams·bioRxiv·Oct 15, 2025
- Type I interferon signaling instills divergent metastatic phenotypes and immunotherapy responses
Cort B. Breuer, Marcos Labrado, … Nathan Edward Reticker-Flynn·bioRxiv·Sep 18, 2025
- IL-1α secreted by subcapsular sinus macrophages promotes melanoma metastasis in the sentinel lymph node by upregulating STAT3 signaling in the tumor.
T. Virgilio, J. Bordini, … S. F. Gonzalez·bioRxiv·Oct 11, 2021